Announcements Trials

Browse Landscape

Phase

Phase 1 3 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Renal Cell 3 Melanoma 2 Kidney Neoplasms 2 Solid Tumors 1 Solid Tumor 1 Skin Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Oncolytic Virotherapy 2 fluoromisonidazole 1 fludarabine 1 aldesleukin 1 adavosertib 1 Radiotherapy, Intensity-Modulated 1 Magnetic Resonance Spectroscopy 1 Luteolin 1 Interleukin-2 1 Fluorodeoxyglucose F18 1 Cyclophosphamide 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carcinoma × Interleukin-2 × Clear all

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Vall d'Hebron Institute of Oncology

Phase EARLY_PHASE1 Recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡